Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress - PubMed (original) (raw)
Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress
J F Cubells et al. J Neurosci. 1994 Apr.
Abstract
Methamphetamine (MA) produces selective degeneration of dopamine (DA) neuron terminals without cell body loss. While excitatory amino acids (EAAs) contribute to MA toxicity, terminal loss is not characteristic of excitotoxic lesions nor is excitotoxicity selective for DA fibers; rather, EAAs may modulate MA-induced DA turnover, suggesting that DA-dependent events play a key role in MA neurotoxicity. To examine this possibility, we used postnatal ventral midbrain DA neuron cultures maintained under continuous EAA blockade. As in vivo, MA caused neurite degeneration but minimal cell death. We found that MA is a vacuologenic weak base that induces swelling of endocytic compartments; MA also induces blebbing of the plasma membrane. However, these morphological changes occurred in MA-treated cultures lacking DA neurons. Therefore, while collapse of endosomal and lysosomal pH gradients and vacuolation may contribute to MA neurotoxicity, this does not explain selective DA terminal degeneration. Alternatively, MA could exert its neurotoxic effects by collapsing synaptic vesicle proton gradients and redistributing DA from synaptic vesicles to the cytoplasm. This could cause the formation of DA-derived free radicals and reactive metabolites. To test whether MA induces oxidative stress within living DA neurons, we used 2,7-dichlorofluorescin diacetate (DCF), an indicator of intracellular hydroperoxide production. MA dramatically increased the number of DCF-labeled cells in ventral midbrain cultures, which contain about 30% DA neurons, but not in nucleus accumbens cultures, which do not contain DA neurons. In the DA neuron cultures, intracellular DDF labeling was localized to axonal varicosities, blebs, and endocytic organelles. These results suggest that MA redistributes DA from the reducing environment within synaptic vesicles to extravesicular oxidizing environments, thus generating oxygen radicals and reactive metabolites within DA neurons that may trigger selective DA terminal loss.
Similar articles
- Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis.
Larsen KE, Fon EA, Hastings TG, Edwards RH, Sulzer D. Larsen KE, et al. J Neurosci. 2002 Oct 15;22(20):8951-60. doi: 10.1523/JNEUROSCI.22-20-08951.2002. J Neurosci. 2002. PMID: 12388602 Free PMC article. - Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis.
Guillot TS, Shepherd KR, Richardson JR, Wang MZ, Li Y, Emson PC, Miller GW. Guillot TS, et al. J Neurochem. 2008 Sep;106(5):2205-17. doi: 10.1111/j.1471-4159.2008.05568.x. Epub 2008 Jul 15. J Neurochem. 2008. PMID: 18643795 Free PMC article. - Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.
Ding YM, Jaumotte JD, Signore AP, Zigmond MJ. Ding YM, et al. J Neurochem. 2004 May;89(3):776-87. doi: 10.1111/j.1471-4159.2004.02415.x. J Neurochem. 2004. PMID: 15086533 - [New perspectives on the mechanism of methamphetamine-induced neurotoxicity].
Kita T, Takeshima M, Wagner GC, Hozumi H, Miyazaki I, Asanuma M. Kita T, et al. Nihon Shinkei Seishin Yakurigaku Zasshi. 2008 Apr;28(2):49-61. Nihon Shinkei Seishin Yakurigaku Zasshi. 2008. PMID: 18516983 Review. Japanese. - Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system.
Dluzen DE, McDermott JL. Dluzen DE, et al. Ann N Y Acad Sci. 2000 Sep;914:112-26. doi: 10.1111/j.1749-6632.2000.tb05189.x. Ann N Y Acad Sci. 2000. PMID: 11085314 Review.
Cited by
- Modulation of BK channel by MicroRNA-9 in neurons after exposure to HIV and methamphetamine.
Tatro ET, Hefler S, Shumaker-Armstrong S, Soontornniyomkij B, Yang M, Yermanos A, Wren N, Moore DJ, Achim CL. Tatro ET, et al. J Neuroimmune Pharmacol. 2013 Dec;8(5):1210-23. doi: 10.1007/s11481-013-9446-8. Epub 2013 Mar 19. J Neuroimmune Pharmacol. 2013. PMID: 23508624 Free PMC article. - Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse.
Regoni M, Zanetti L, Comai S, Mercatelli D, Novello S, Albanese F, Croci L, Consalez GG, Ciammola A, Valtorta F, Morari M, Sassone J. Regoni M, et al. Biomedicines. 2021 May 5;9(5):514. doi: 10.3390/biomedicines9050514. Biomedicines. 2021. PMID: 34063112 Free PMC article. - Role of monoamine transporters in mediating psychostimulant effects.
Riddle EL, Fleckenstein AE, Hanson GR. Riddle EL, et al. AAPS J. 2005 Dec 20;7(4):E847-51. doi: 10.1208/aapsj070481. AAPS J. 2005. PMID: 16594636 Free PMC article. Review. - Methamphetamine causes depletion of glutathione and an increase in oxidized glutathione in the rat striatum and prefrontal cortex.
Açikgöz O, Gönenç S, Gezer S, Kayatekin BM, Uysal N, Semin I, Gure A. Açikgöz O, et al. Neurotox Res. 2001 Jul;3(3):277-80. doi: 10.1007/BF03033266. Neurotox Res. 2001. PMID: 15111252 - Neurotoxins: free radical mechanisms and melatonin protection.
Reiter RJ, Manchester LC, Tan DX. Reiter RJ, et al. Curr Neuropharmacol. 2010 Sep;8(3):194-210. doi: 10.2174/157015910792246236. Curr Neuropharmacol. 2010. PMID: 21358970 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials